BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chade AR, Williams ML, Engel JE, Williams E, Bidwell GL 3rd. Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-κB improves renal recovery in chronic kidney disease. Am J Physiol Renal Physiol 2020;319:F139-48. [PMID: 32538151 DOI: 10.1152/ajprenal.00155.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Engel JE, Williams ML, Williams E, Azar C, Taylor EB, Bidwell GL, Chade AR. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease. Am J Nephrol 2020;51:891-902. [PMID: 33130676 DOI: 10.1159/000511260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uddin MJ, Farjana M, Moni A, Hossain KS, Hannan MA, Ha H. Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging. Int J Mol Sci 2021;22:8258. [PMID: 34361023 DOI: 10.3390/ijms22158258] [Reference Citation Analysis]
3 Wang J, Ge S, Wang Y, Liu Y, Qiu L, Li J, Huang X, Sun L. Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways. Drug Des Devel Ther 2021;15:3697-708. [PMID: 34465981 DOI: 10.2147/DDDT.S321879] [Reference Citation Analysis]
4 Chade AR, Engel JE, Hall ME, Eirin A, Bidwell GL 3rd. INTRA-RENAL MODULATION OF NF-κB ACTIVITY ATTENUATES CARDIAC INJURY IN A SWINE MODEL OF CKD: A RENAL-CARDIO AXIS. Am J Physiol Renal Physiol 2021. [PMID: 34396789 DOI: 10.1152/ajprenal.00158.2021] [Reference Citation Analysis]
5 He D, Li Q, Du G, Meng G, Sun J, Chen S. An Integration of Network Pharmacology and Experimental Verification to Investigate the Mechanism of Guizhi to Treat Nephrotic Syndrome. Front Pharmacol 2021;12:755421. [PMID: 34925015 DOI: 10.3389/fphar.2021.755421] [Reference Citation Analysis]